Disease-free survival (DFS) data indicates high expression of CCNA2 is related to poor prognosis in cancers of ACC (p = 0.0057), BLCA (p = 0.049), KIRP (p < 0.001), LGG (p < 0.001), LIHC (p = 0.0039), PAAD (p = 0.038), PRAD (p = 0.0015), SARC (p = 0.0014), THCA (p = 0.0025), UVM (p = 0.0064) (Figure 2B). This evidence concerns the gene CCNA2 and adrenal cortex carcinoma.